Tag: Bispecific antibodies

The term "bite therapy" can refer to two entirely different medical treatments: dental solutions for jaw alignment and teeth grinding, or a specific type of cancer immunotherapy called Bispecific T-cell Engager (BiTE) therapy. Each carries a distinct set of potential side effects, making it crucial to understand which treatment is being discussed.

Over 20 clinical candidates engineered with Xencor's XmAb technology are currently in development, showcasing its broad application in medicine. So, what is XmAb? It is a proprietary protein engineering platform that modifies the fragment crystallizable (Fc) domain of antibodies to enhance their therapeutic properties.